Low Energy HoLEP on IPSS
NCT04514718 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2020-08-17
Summary
The purpose of this study is to prove that low-energy (30W) Holmium laser prostatectomy (Holeb) is not inferior to high-energy (100W) Holmium laser prostatectomy (safety and effectiveness)
Conditions
- Prostate Hyperplasia
- Prostatic Hypertrophy
- Surgery
- Bladder Outlet Obstruction
- Quality of Life
- Complication of Surgical Procedure
Interventions
- DEVICE
-
Holmium laser
low energy holmium laser
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Max Age
- 90 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-08-24
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
More Related Trials
-
Transperineal Laser Ablation for Low- and Intermediate Risk Prostate Cancer: a Single Cohort Analysis
NCT05584787 ·Status: RECRUITING ·Phase: NA
-
Comparison of Prostate Cancer-related Quality of Life in Sexually Active Men With Favourable Intermediate-risk Localised Prostate Cancer Treated With Total Prostatectomy or Focal HIFU
NCT06945172 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Transperineal Laser Ablation Treatment (TPLA) for Prostate Cancer (PCa) Registry
NCT05163197 ·Status: RECRUITING
-
Evaluation of the Application Effect of a Surgical Navigation System in HoLEP Surgery
NCT07251621 ·Status: COMPLETED ·Phase: NA
-
Transperineal Laser Ablation for Focal Treatment of Prostate Cancer
NCT04170478 ·Status: COMPLETED ·Phase: NA
-
Moses Vaporization: Is Use of Moses 2.0 in Holmium Laser Ablation of the Prostate More Efficient
NCT04979143 ·Status: TERMINATED ·Phase: NA
-
Multi-modality Prostate Cancer Image Guided Interventions
NCT04009174 ·Status: COMPLETED ·Phase: NA
-
Hypofractionated Radiotherapy for Localized Prostate Cancer (With CyberKnife or With IMRT)
NCT00855647 ·Status: COMPLETED ·Phase: PHASE2
-
Hypofractionated Whole Pelvic Radiotherapy of the Prostate
NCT02546427 ·Status: WITHDRAWN ·Phase: NA
-
Potency pReservation In Prostate cAncer Patients Treated With UltraSound-guided Low-dose Rate Brachytherapy
NCT04718987 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Early Home Return in Patients With Enucleation of Prostate Adenoma
NCT05912764 ·Status: RECRUITING ·Phase: NA
-
Effectiveness of Localized Prostate Cancer Treatments
NCT01492751 ·Status: ACTIVE_NOT_RECRUITING
-
Outcomes of Focal Ablation for Prostate Cancer
NCT05478694 ·Status: RECRUITING
-
CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
NCT00643617 ·Status: COMPLETED ·Phase: NA
-
Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors
NCT02600156 ·Status: COMPLETED ·Phase: NA
-
Focal Laser Ablation in Prostate Cancer
NCT06916013 ·Status: NOT_YET_RECRUITING
-
Ablative Therapy in the Management of Prostate Cancer
NCT03492424 ·Status: RECRUITING
-
Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
NCT07325721 ·Status: RECRUITING ·Phase: PHASE2
-
Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer
NCT04597411 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer
NCT00714753 ·Status: COMPLETED ·Phase: PHASE2
-
Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer
NCT04197141 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation of Four Treatment Modalities in Prostate Cancer With Low or "Early Intermediate" Risk
NCT01717677 ·Status: TERMINATED ·Phase: NA
-
Salvage Prostatectomy After Radiotherapy
NCT00791115 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate a New Method to Detect Residual Tumours During Surgery for Prostate Cancer Using Confocal Microscopy
NCT06398470 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-III)
NCT06914544 ·Status: RECRUITING ·Phase: NA